Literature DB >> 23608320

Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis.

Fernanda L Fonseca1, Allan J Guimarães, Lívia Kmetzsch, Fabianno F Dutra, Fernanda D Silva, Carlos P Taborda, Glauber de S Araujo, Susana Frases, Charley C Staats, Marcelo T Bozza, Augusto Schrank, Marilene H Vainstein, Leonardo Nimrichter, Arturo Casadevall, Marcio L Rodrigues.   

Abstract

The principal capsular component of Cryptococcus neoformans, glucuronoxylomannan (GXM), interacts with surface glycans, including chitin-like oligomers. Although the role of GXM in cryptococcal infection has been well explored, there is no information on how chitooligomers affect fungal pathogenesis. In this study, surface chitooligomers of C. neoformans were blocked through the use of the wheat germ lectin (WGA) and the effects on animal pathogenesis, interaction with host cells, fungal growth and capsule formation were analyzed. Treatment of C. neoformans cells with WGA followed by infection of mice delayed mortality relative to animals infected with untreated fungal cells. This observation was associated with reduced brain colonization by lectin-treated cryptococci. Blocking chitooligomers also rendered yeast cells less efficient in their ability to associate with phagocytes. WGA did not affect fungal viability, but inhibited GXM release to the extracellular space and capsule formation. In WGA-treated yeast cells, genes that are involved in capsule formation and GXM traffic had their transcription levels decreased in comparison with untreated cells. Our results suggest that cellular pathways required for capsule formation and pathogenic mechanisms are affected by blocking chitin-derived structures at the cell surface of C. neoformans. Targeting chitooligomers with specific ligands may reveal new therapeutic alternatives to control cryptococcosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Capsule; Chitin oligosaccharides; Cryptococcus neoformans; Lectin binding; Virulence

Mesh:

Substances:

Year:  2013        PMID: 23608320      PMCID: PMC4294701          DOI: 10.1016/j.fgb.2013.04.005

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  62 in total

1.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.

Authors:  Erin E McClelland; André M Nicola; Rafael Prados-Rosales; Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Fusarium sp. growth inhibition by wheat germ agglutinin.

Authors:  J Ciopraga; O Gozia; R Tudor; L Brezuica; R J Doyle
Journal:  Biochim Biophys Acta       Date:  1999-08-05

Review 3.  Intracellular parasitism of macrophages by Cryptococcus neoformans.

Authors:  M Feldmesser; S Tucker; A Casadevall
Journal:  Trends Microbiol       Date:  2001-06       Impact factor: 17.079

4.  An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation.

Authors:  Vera Carolina B Bittencourt; Rodrigo T Figueiredo; Rosana B da Silva; Diego S Mourão-Sá; Patricia L Fernandez; Guilherme L Sassaki; Barbara Mulloy; Marcelo T Bozza; Eliana Barreto-Bergter
Journal:  J Biol Chem       Date:  2006-06-09       Impact factor: 5.157

5.  The vacuolar Ca²(+) exchanger Vcx1 is involved in calcineurin-dependent Ca²(+) tolerance and virulence in Cryptococcus neoformans.

Authors:  Lívia Kmetzsch; Charley Christian Staats; Elisa Simon; Fernanda L Fonseca; Débora L de Oliveira; Luna Sobrino; Jéssica Rodrigues; Ana Lusia Leal; Leonardo Nimrichter; Márcio L Rodrigues; Augusto Schrank; Marilene Henning Vainstein
Journal:  Eukaryot Cell       Date:  2010-10-01

Review 6.  Preventing deaths from cryptococcal meningitis: from bench to bedside.

Authors:  Monika Roy; Tom Chiller
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

7.  TLR4 recognizes Pseudallescheria boydii conidia and purified rhamnomannans.

Authors:  Rodrigo T Figueiredo; Patrícia L Fernandez; Fabianno F Dutra; Yissett González; Lívia Cristina Lopes; Vera Carolina B Bittencourt; Guilherme L Sassaki; Eliana Barreto-Bergter; Marcelo T Bozza
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

8.  Monoclonal antibody based ELISAs for cryptococcal polysaccharide.

Authors:  A Casadevall; J Mukherjee; M D Scharff
Journal:  J Immunol Methods       Date:  1992-09-18       Impact factor: 2.303

9.  Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties.

Authors:  Caroline L Ramos; Fernanda L Fonseca; Jessica Rodrigues; Allan J Guimarães; Leonardo P Cinelli; Kildare Miranda; Leonardo Nimrichter; Arturo Casadevall; Luiz R Travassos; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2012-05-04

10.  Role of IL-17A on resolution of pulmonary C. neoformans infection.

Authors:  Karen L Wozniak; Sarah E Hardison; Jay K Kolls; Floyd L Wormley
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

View more
  15 in total

1.  The unappreciated intracellular lifestyle of Blastomyces dermatitidis.

Authors:  Alana K Sterkel; Robert Mettelman; Marcel Wüthrich; Bruce S Klein
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

Review 2.  New technology and resources for cryptococcal research.

Authors:  Nannan Zhang; Yoon-Dong Park; Peter R Williamson
Journal:  Fungal Genet Biol       Date:  2014-11-15       Impact factor: 3.495

Review 3.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 4.  Unraveling synthesis of the cryptococcal cell wall and capsule.

Authors:  Zhuo A Wang; Lucy X Li; Tamara L Doering
Journal:  Glycobiology       Date:  2018-10-01       Impact factor: 4.313

Review 5.  Cryptococcus neoformans: historical curiosity to modern pathogen.

Authors:  Deepa Srikanta; Felipe H Santiago-Tirado; Tamara L Doering
Journal:  Yeast       Date:  2014-01-19       Impact factor: 3.239

6.  Monoclonal Antibodies against Cell Wall Chitooligomers as Accessory Tools for the Control of Cryptococcosis.

Authors:  Alexandre Bezerra Conde Figueiredo; Fernanda L Fonseca; Diogo Kuczera; Fernando de Paiva Conte; Marcia Arissawa; Marcio L Rodrigues
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

7.  Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomers.

Authors:  Susie Coutinho Liedke; Daniel Zamith Miranda; Kamilla Xavier Gomes; Jorge Luis S Gonçalves; Susana Frases; Joshua D Nosanchuk; Marcio L Rodrigues; Leonardo Nimrichter; José Mauro Peralta; Allan J Guimarães
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

8.  Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates.

Authors:  Jéssica Rodrigues; Fernanda L Fonseca; Rafael O Schneider; Rodrigo M da C Godinho; Carolina Firacative; Krystyna Maszewska; Wieland Meyer; Augusto Schrank; Charley Staats; Livia Kmetzsch; Marilene H Vainstein; Marcio L Rodrigues
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

9.  Modulation of Zinc Homeostasis in Acanthamoeba castellanii as a Possible Antifungal Strategy against Cryptococcus gattii.

Authors:  Nicole S Ribeiro; Francine M Dos Santos; Ane W A Garcia; Patrícia A G Ferrareze; Laura F Fabres; Augusto Schrank; Livia Kmetzsch; Marilise B Rott; Marilene H Vainstein; Charley C Staats
Journal:  Front Microbiol       Date:  2017-08-24       Impact factor: 5.640

Review 10.  The status of cryptococcosis in Latin America.

Authors:  Carolina Firacative; Jairo Lizarazo; María Teresa Illnait-Zaragozí; Elizabeth Castañeda
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-04-05       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.